BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33443677)

  • 1. Clinical Impact of Pathological Features Including the Ki-67 Labeling Index on Diagnosis and Prognosis of Adult and Pediatric Adrenocortical Tumors.
    Martins-Filho SN; Almeida MQ; Soares I; Wakamatsu A; Alves VAF; Fragoso MCBV; Zerbini MCN
    Endocr Pathol; 2021 Jun; 32(2):288-300. PubMed ID: 33443677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: Is there a correlation?
    Das S; Sengupta M; Islam N; Roy P; Datta C; Mishra PK; Banerjee S; Chaudhuri MK; Chatterjee U
    J Pediatr Surg; 2016 Nov; 51(11):1795-1800. PubMed ID: 27567308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children.
    Chatterjee G; DasGupta S; Mukherjee G; Sengupta M; Roy P; Arun I; Datta C; Mishra PK; Banerjee S; Chatterjee U
    Pediatr Surg Int; 2015 Jun; 31(6):563-71. PubMed ID: 25895073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas.
    Morimoto R; Satoh F; Murakami O; Suzuki T; Abe T; Tanemoto M; Abe M; Uruno A; Ishidoya S; Arai Y; Takahashi K; Sasano H; Ito S
    Endocr J; 2008 Mar; 55(1):49-55. PubMed ID: 18187873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
    Mete O; Erickson LA; Juhlin CC; de Krijger RR; Sasano H; Volante M; Papotti MG
    Endocr Pathol; 2022 Mar; 33(1):155-196. PubMed ID: 35288842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the role of the pathological grading in pediatric adrenal cortical tumors: results from a national cohort study with pathological review.
    Picard C; Orbach D; Carton M; Brugieres L; Renaudin K; Aubert S; Berrebi D; Galmiche L; Dujardin F; Leblond P; Thomas-Teinturier C; Dijoud F
    Mod Pathol; 2019 Apr; 32(4):546-559. PubMed ID: 30401946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone mRNA in situ hybridization and Ki 67 immunohistochemistry in pediatric adrenocortical tumors.
    Orhan D; Kale G; Cağlar M; Göğüş S; Karaağaoğlu E
    Virchows Arch; 2006 May; 448(5):591-6. PubMed ID: 16489441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.
    Yamazaki Y; Nakamura Y; Shibahara Y; Konosu-Fukaya S; Sato N; Kubota-Nakayama F; Oki Y; Baba S; Midorikawa S; Morimoto R; Satoh F; Sasano H
    Hum Pathol; 2016 Jul; 53():41-50. PubMed ID: 26980031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Adrenocortical Neoplasms: A Study Comparing Three Histopathological Scoring Systems.
    Jangir H; Ahuja I; Agarwal S; Jain V; Meena JP; Agarwala S; Sharma R; Sharma MC; Iyer VK; Mani K
    Endocr Pathol; 2023 Jun; 34(2):213-223. PubMed ID: 37160532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.
    Pennanen M; Heiskanen I; Sane T; Remes S; Mustonen H; Haglund C; Arola J
    Hum Pathol; 2015 Mar; 46(3):404-10. PubMed ID: 25582500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
    Beuschlein F; Weigel J; Saeger W; Kroiss M; Wild V; Daffara F; Libé R; Ardito A; Al Ghuzlan A; Quinkler M; Oßwald A; Ronchi CL; de Krijger R; Feelders RA; Waldmann J; Willenberg HS; Deutschbein T; Stell A; Reincke M; Papotti M; Baudin E; Tissier F; Haak HR; Loli P; Terzolo M; Allolio B; Müller HH; Fassnacht M
    J Clin Endocrinol Metab; 2015 Mar; 100(3):841-9. PubMed ID: 25559399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic utility of SF-1 in adrenal cortical tumours.
    Maity P; Mondal A; Das R; Sengupta M; Gargari P; Kar A; Sarkar D; Mukhopadhyay S; Chowdhury S; Chatterjee U
    Indian J Pathol Microbiol; 2022; 65(4):814-820. PubMed ID: 36308186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
    Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M
    Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric adrenocortical tumors: morphological diagnostic criteria and immunohistochemical expression of matrix metalloproteinase type 2 and human leucocyte-associated antigen (HLA) class II antigens. Results from the Italian Pediatric Rare Tumor (TREP) Study project.
    Magro G; Esposito G; Cecchetto G; Dall'Igna P; Marcato R; Gambini C; Boldrini R; Collini P; D'Onofrio V; Salfi N; d'Amore E; Ferrari A; Bisogno G; Alaggio R
    Hum Pathol; 2012 Jan; 43(1):31-9. PubMed ID: 21820153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical prognostic factors in pediatric adrenocortical tumors: A meta-analysis.
    Zambaiti E; Duci M; De Corti F; Gamba P; Dall'Igna P; Ghidini F; Virgone C
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28836. PubMed ID: 33306282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
    Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
    Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
    Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
    Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma.
    Papathomas TG; Pucci E; Giordano TJ; Lu H; Duregon E; Volante M; Papotti M; Lloyd RV; Tischler AS; van Nederveen FH; Nose V; Erickson L; Mete O; Asa SL; Turchini J; Gill AJ; Matias-Guiu X; Skordilis K; Stephenson TJ; Tissier F; Feelders RA; Smid M; Nigg A; Korpershoek E; van der Spek PJ; Dinjens WN; Stubbs AP; de Krijger RR
    Am J Surg Pathol; 2016 Apr; 40(4):569-76. PubMed ID: 26685085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.
    Michalkiewicz E; Sandrini R; Figueiredo B; Miranda EC; Caran E; Oliveira-Filho AG; Marques R; Pianovski MA; Lacerda L; Cristofani LM; Jenkins J; Rodriguez-Galindo C; Ribeiro RC
    J Clin Oncol; 2004 Mar; 22(5):838-45. PubMed ID: 14990639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the pathologist in evaluating surrogate markers for medical therapy in adrenocortical carcinoma.
    Sasano H; Satoh F; Nakamura Y
    Endocr Pathol; 2014 Dec; 25(4):366-70. PubMed ID: 25252621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.